Cardiopulmonary toxicity after liposomal amphotericin B infusion.
Levine
S J
SJ
National Institutes of Health, Bethesda, Maryland.
Walsh
T J
TJ
Martinez
A
A
Eichacker
P Q
PQ
Lopez-Berestein
G
G
Natanson
C
C
D000328:Adult; D000666:Amphotericin B / Q000008:administration & dosage* / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004337:Drug Carriers; D005260:Female; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D007262:Infusions, Intravenous; D008081:Liposomes; D008168:Lung / Q000098:blood supply; D008171:Lung Diseases / Q000139:chemically induced* / Q000503:physiopathology; D011659:Pulmonary Gas Exchange / Q000187:drug effects
D004337:Drug Carriers; D008081:Liposomes; D000666:Amphotericin B